Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.
Dummer R, Beyer M, Hymes K, Epping MT, Bernards R, Steinhoff M, Sterry W, Kerl H, Heath K, Ahern JD, Hardwick JS, Garcia-Vargas J, Baumann K, Rizvi S, Frankel SR, Whittaker SJ, Assaf C. Dummer R, et al. Among authors: epping mt. Leuk Lymphoma. 2012 Aug;53(8):1501-8. doi: 10.3109/10428194.2012.656625. Epub 2012 Feb 13. Leuk Lymphoma. 2012. PMID: 22239668 Clinical Trial.
PRAME expression and clinical outcome of breast cancer.
Epping MT, Hart AA, Glas AM, Krijgsman O, Bernards R. Epping MT, et al. Br J Cancer. 2008 Aug 5;99(3):398-403. doi: 10.1038/sj.bjc.6604494. Epub 2008 Jul 22. Br J Cancer. 2008. PMID: 18648365 Free PMC article.
Apoptosis: target of cancer therapy.
Ferreira CG, Epping M, Kruyt FA, Giaccone G. Ferreira CG, et al. Clin Cancer Res. 2002 Jul;8(7):2024-34. Clin Cancer Res. 2002. PMID: 12114400 Review.
15 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page